MRK SEC Filings: 8-K, 10-Q, S-3 & 424B – Merck &

Financials

TYPE

HEADLINE

FILED AT

News

TYPE

HEADLINE

FILED AT

8-K

Merck Announces Third-Quarter 2026 Financial Results and Raises Full-Year Sales and EPS Outlook

Oct 29, 2026

8-K

Paul J. Diaz Elected to Merck & Co., Inc. Board of Directors

Oct 13, 2026

8-K

Merck Announces Second-Quarter 2026 Financial Results and Raises Full-Year Outlook

Aug 4, 2026

8-K

Merck & Co., Inc. Announces Results of 2026 Annual Meeting of Shareholders

May 28, 2026

8-K

Merck & Co., Inc. Completes $6 Billion Public Offering of Senior Notes

May 22, 2026

8-K

Merck Announces First-Quarter 2026 Financial Results and Strategic Pipeline Expansion

Apr 30, 2026

Prospectus

TYPE

HEADLINE

FILED AT

424B5

REGISTERED OFFERING

May 20, 2026

424B5

FIXED PRICE OFFERING | Bank: Citigroup, BofA Securities, Goldman Sachs & Co. LLC, J.P. Morgan

May 18, 2026

424B5

FIXED PRICE OFFERING | Offering amount: $8,000,000,000 | Bank: Citigroup, BNP Paribas, Deutsche Bank Securities, HSBC

Dec 3, 2025

424B5

PENDING FIXED PRICE OFFERING | Bank: Citigroup, BNP Paribas, Deutsche Bank Securities, HSBC

Dec 1, 2025

424B5

FIXED PRICE OFFERING | Offering amount: $6,000,000,000 | Bank: BofA Securities

Sep 4, 2025

424B5

PENDING FIXED PRICE OFFERING | Bank: BofA Securities, Goldman Sachs & Co. LLC, J.P. Morgan, Mizuho

Sep 2, 2025

Registrations

TYPE

HEADLINE

FILED AT

FWP

Form FWP - Filing under Securities Act Rules 163/433 of free writing prospectuses

May 18, 2026

SC TO-T/A

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

May 5, 2026

SC TO-T/A

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Apr 24, 2026

SC TO-T

Form SC TO-T - Tender offer statement by Third Party

Apr 7, 2026

SC TO-T/A

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Jan 7, 2026

SC TO-T/A

Form SC TO-T/A - Tender offer statement by Third Party: [Amend]

Dec 19, 2025

Proxies

TYPE

HEADLINE

FILED AT

Ownerships

TYPE

HEADLINE

FILED AT

DIAZ PAUL J (Reporting)

Nov 3, 2026

DIAZ PAUL J (Reporting)

Nov 3, 2026

144

Form 144 - Report of proposed sale of securities

Nov 2, 2026

3/A

Maraldo David R. (Reporting)

Oct 22, 2026

Seidman Christine E (Reporting)

Oct 1, 2026

Karsanbhai Surendralal Lanca (Reporting)

Oct 1, 2026

Other

TYPE

HEADLINE

FILED AT

Form SD - Specialized disclosure report

May 29, 2026

Form SD - Specialized disclosure report

May 30, 2025

LETTER

Form UPLOAD - SEC-generated letter

Apr 28, 2025

CORRESP

Form CORRESP - Correspondence

Apr 16, 2025

LETTER

Form UPLOAD - SEC-generated letter

Apr 10, 2025

Form SD - Specialized disclosure report

May 28, 2024

Merck & Co., Inc. MRK · SEC Filings